Mesh : Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Chemotherapy, Adjuvant Dacarbazine / analogs & derivatives therapeutic use Dermatologic Surgical Procedures Humans Imidazoles / therapeutic use Indoles / therapeutic use Ipilimumab Lymph Node Excision Melanoma / pathology therapy Neoplasm Staging Nivolumab Oximes / therapeutic use Practice Guidelines as Topic Radiotherapy, Adjuvant Sentinel Lymph Node Biopsy Skin Neoplasms / pathology therapy Sulfonamides / therapeutic use Switzerland Temozolomide Vemurafenib

来  源:   DOI:10.4414/smw.2016.14279

Abstract:
Cutaneous melanoma is the most deadly cutaneous neoplasm. In order to guide treatment decisions and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland were inaugurated in 2001 and revised in 2006 and 2016. Recent data on surgical and medical treatments from randomised trials necessitated modification of the treatment and follow-up recommendations.
摘要:
暂无翻译
公众号